|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 453.05 DKK | +0.53% |
|
-7.16% | -27.42% |
| 02:00pm | Sector Update: Health Care Stocks Higher in Afternoon Trading | MT |
| 01:34pm | Sector Update: Health Care | MT |
| Capitalization | 2,000B 312B 268B 251B 229B 427B 26,796B 479B 2,968B 1,140B 12,346B 1,169B 1,145B 45,120B | P/E ratio 2025 * |
17.2x | P/E ratio 2026 * | 14.5x |
|---|---|---|---|---|---|
| Enterprise value | 2,068B 322B 277B 259B 236B 442B 27,701B 495B 3,068B 1,179B 12,763B 1,209B 1,184B 46,644B | EV / Sales 2025 * |
6.23x | EV / Sales 2026 * | 5.34x |
| Free-Float |
70.25% | Yield 2025 * |
2.92% | Yield 2026 * | 3.41% |
More valuation ratios
* Estimated data
More news
Last Transcript: Novo Nordisk A/S
More recommendations
More press releases
More news
| 1 day | +0.53% | ||
| 1 week | -7.16% | ||
| Current month | -0.13% | ||
| 1 month | -1.58% | ||
| 3 months | -13.16% | ||
| 6 months | -28.75% | ||
| Current year | -27.42% |
| 1 week | 442.15 |  | 492.85 |
| 1 month | 442.15 | | 533.4 |
| Current year | 380 | | 675.2 |
| 1 year | 380 | | 1,033.2 |
| 3 years | 365.3 | | 1,033.2 |
| 5 years | 200.1 | | 1,033.2 |
| 10 years | 109.1 | | 1,033.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 2016-12-31 | |
| Director of Finance/CFO | 54 | 2018-02-14 | |
Marcus Schindler
CTO | Chief Tech/Sci/R&D Officer | 58 | 2021-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Sylvie Grégoire
BRD | Director/Board Member | 64 | 2015-03-18 |
Kasim Kutay
BRD | Director/Board Member | 60 | 2017-03-22 |
Helge Lund
CHM | Chairman | 62 | 2018-03-21 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 21.31% | 200 M€ | -4.24% | - | |
| 10.45% | 4 M€ | +20.61% | - | |
| 5.4% | 21 M€ | +1.41% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.53% | -7.16% | -54.16% | +15.24% | 310B | ||
| +0.41% | -2.05% | -12.93% | +138.00% | 692B | ||
| +0.78% | -0.05% | +2.14% | -16.45% | 364B | ||
| +1.09% | +0.22% | +7.61% | +22.02% | 325B | ||
| +0.61% | +0.19% | +2.62% | -17.79% | 257B | ||
| +0.36% | -0.16% | -0.61% | +18.39% | 229B | ||
| -0.84% | -3.10% | -17.20% | -4.12% | 218B | ||
| -0.17% | +2.22% | -39.82% | -14.08% | 201B | ||
| +2.75% | -3.68% | -12.18% | +13.86% | 146B | ||
| +1.14% | +1.21% | -14.35% | -52.92% | 137B | ||
| Average | +0.66% | -4.33% | -13.89% | +10.22% | 287.91B | |
| Weighted average by Cap. | +0.58% | -4.86% | -13.01% | +31.98% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 332B 51.74B 44.49B 41.63B 37.97B 70.89B 4,448B 79.48B 493B 189B 2,049B 194B 190B 7,489B | 381B 59.33B 51.02B 47.73B 43.54B 81.29B 5,100B 91.14B 565B 217B 2,350B 223B 218B 8,588B |
| Net income | 117B 18.22B 15.67B 14.66B 13.37B 24.96B 1,566B 27.98B 173B 66.64B 721B 68.34B 66.9B 2,637B | 138B 21.51B 18.5B 17.31B 15.79B 29.47B 1,849B 33.04B 205B 78.7B 852B 80.7B 79B 3,114B |
| Net Debt | 67.55B 10.53B 9.05B 8.47B 7.72B 14.42B 905B 16.17B 100B 38.51B 417B 39.49B 38.66B 1,524B | 34.58B 5.39B 4.63B 4.33B 3.95B 7.38B 463B 8.28B 51.3B 19.71B 213B 20.21B 19.79B 780B |
More financial data
* Estimated data
Employees
77,406
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-24 | 453.05 kr | +0.53% | 3,428,521 |
| 25-06-23 | 450.65 kr | -5.29% | 6,558,504 |
| 25-06-20 | 475.80 kr | -2.58% | 6,611,471 |
| 25-06-19 | 488.40 kr | +1.22% | 2,151,553 |
| 25-06-18 | 482.50 kr | -1.13% | 3,350,615 |
Delayed Quote Nasdaq Copenhagen, June 24, 2025 at 11:20 am
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
450.65DKK
Average target price
662.18DKK
Spread / Average Target
+46.94%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVO B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition